203729
(+)-Brefeldin A，来源于布雷正青霉菌
Specifically and reversibly blocks translocation of proteins from the endoplasmic reticulum (ER) to the Golgi apparatus without affecting endocytosis or lysosome function.
别名:
(+)-Brefeldin A，来源于布雷正青霉菌, 1,6,7,8,9,11a,12,13,14,14a-十氢-1,13-二羟基-6-甲基-4H-环戊[f]氧杂环十三烷-4-酮（布雷非德菌素 A）
登录查看公司和协议定价
所有图片(1)
About This Item
推荐产品
品質等級
化驗
≥95% (HPLC)
形狀
crystalline solid
製造商／商標名
Calbiochem®
儲存條件
OK to freeze
顏色
white
溶解度
methanol: 2 mg/mL
運輸包裝
ambient
儲存溫度
−20°C
InChI
1S/C16H24O4/c1-11-5-3-2-4-6-12-9-13(17)10-14(12)15(18)7-8-16(19)20-11/h4,6-8,11-15,17-18H,2-3,5,9-10H2,1H3/b6-4+,8-7+/t11-,12+,13-,14+,15-/m0/s1
InChI 密鑰
KQNZDYYTLMIZCT-PNFJWZTBSA-N
一般說明
特异且可逆地阻断蛋白质从内质网（ER）向高尔基体转运，而不影响内吞或溶酶体功能。HDL介导的胆固醇外流的抑制剂。<40 ng/ml. Blocks binding of ADP-ribosylation factor to the Golgi and inhibits the GDP-GTP exchange. Inhibits the activity of BIG1 and BIG2, the guanine-nucleotide exchange proteins for ADP-ribosylation factors. Also available as a 25 mM solution in DMSO (Cat. No. 500583可导致多种哺乳动物细胞中的高尔基体解体和ER肿胀。
特异且可逆地阻断蛋白质从内质网（ER）向高尔基体转运，而不影响内吞或溶酶体功能。HDL介导的胆固醇外流的抑制剂。<40 ng/ml可导致多种哺乳动物细胞中的高尔基体解体和ER肿胀。抑制鸟嘌呤核苷酸交换蛋白BIG1和BIG2对ADP-核糖基化因子的活性。阻止ADP-核糖基化因子与高尔基体结合，抑制GDP-GTP交换。
生化／生理作用
主要目的
阻断蛋白质从内质网（ER）向高尔基体转运
阻断蛋白质从内质网（ER）向高尔基体转运
产品不与ATP竞争。
可逆性：是
细胞渗透性：否
警告
毒性：有害（C）
重構
溶解后，等分并冷冻保存（-20°C）。储备溶液在-20°C下可稳定保存2个月。
其他說明
Yamagi, R., et al. 2000.Proc.Natl.Acad.Sci. USA 97, 2567.
Moriango, N., et al. 1996.Proc.Natl.Acad.Sci. USA 93, 12856.
Mendez, A.J.1995.J. Biol. Chem. 270, 5891.
Ridgway, N.D., et al. 1995.J. Biol. Chem. 270, 8023.
Tsai, S.C., et al. 1994.Proc.Natl.Acad.Sci. USA91, 3063.
Ktistakis, N.Y., et al. 1992.Nature356, 344.
Moriango, N., et al. 1996.Proc.Natl.Acad.Sci. USA 93, 12856.
Mendez, A.J.1995.J. Biol. Chem. 270, 5891.
Ridgway, N.D., et al. 1995.J. Biol. Chem. 270, 8023.
Tsai, S.C., et al. 1994.Proc.Natl.Acad.Sci. USA91, 3063.
Ktistakis, N.Y., et al. 1992.Nature356, 344.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Danger
危險聲明
危險分類
Acute Tox. 3 Oral
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
其他客户在看
Tonke K Raaijmakers et al.
Journal for immunotherapy of cancer, 8(1) (2020-05-29)
Tumor ablation techniques, like cryoablation, are successfully used in the clinic to treat tumors. The tumor debris remaining in situ after ablation is a major antigen depot, including neoantigens, which are presented by dendritic cells (DCs) in the draining lymph
Daniela Cunha et al.
Cells, 13(11) (2024-06-19)
Basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) are high-incidence, non-melanoma skin cancers (NMSCs). The success of immune-targeted therapies in advanced NMSCs led us to anticipate that NMSCs harbored significant populations of tumor-infiltrating lymphocytes with potential anti-tumor activity. The
Shreyasi Maity et al.
Infection and immunity, 91(10), e0026723-e0026723 (2023-09-19)
In view of the antagonism of Wnt5A signaling toward microbial pathogens, we were interested in evaluating the therapeutic potential of recombinant Wnt5A (rWnt5A) in curbing Leishmania donovani infection. Initially, using L. donovani-infected RAW 264.7 and peritoneal macrophages, we demonstrated that
Yan Lin et al.
Journal of immunology research, 2021, 8899674-8899674 (2021-01-26)
Tuberculosis is the world's most deadly infectious disease, with 10 million people falling ill and 1.5 million people dying from the disease every year. With the increasing number of drug-resistant Mycobacterium tuberculosis (MTB) strains and prevalence of coinfection of MTB
Kai Bartkowiak et al.
Cancers, 13(3) (2021-02-06)
(1) Background: the early detection of cancer cells in the blood or bone marrow of breast cancer patients improves the understanding of metastasis. Disseminating tumor cells in the bone marrow with a pronounced manifestation of mesenchymal markers (mDTC) are difficult
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门